Further research reveals that this functional abnormality of negative co-stimulatory molecules appears to be mediated by soluble PD-1 (sPD-1), which is secreted abundantly in the serum and synovial fluid of RA patients. This evidence concerns the gene PDCD1 and rheumatoid arthritis.